Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAR-T cell therapy: Where are we now, and where are we heading? | Blood Sci | 2023 | 37941917 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37941812 | PubTator, text mining | PubMed |
| Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer. | Mil Med Res | 2023 | 37941075 | PubTator, text mining | PubMed |
| Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs. | Nature | 2023 | 37938785 | PubTator, text mining | PubMed |
| Targeting of intracellular oncoproteins with peptide-centric CARs. | Nature | 2023 | 37938771 | PubTator, text mining | PubMed |
| Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering. | Nat Commun | 2023 | 37938576 | PubTator, text mining | PubMed |
| Systematic analysis of various RNA transcripts and construction of biological regulatory networks at the post-transcriptional level for chronic obstructive pulmonary disease. | J Transl Med | 2023 | 37936118 | PubTator, text mining | PubMed |
| Harnessing CD3 diversity to optimize CAR T cells. | Nat Immunol | 2023 | 37932456 | PubTator, text mining | PubMed |
| γδ T cells as a potential therapeutic agent for glioblastoma. | Front Immunol | 2023 | 37928546 | PubTator, text mining | PubMed |
| Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature. | Front Oncol | 2023 | 37927469 | PubTator, text mining | PubMed |
| Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure. | Chin Med J (Engl) | 2023 | 37927030 | PubTator, text mining | PubMed |
| CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models. | J Exp Clin Cancer Res | 2023 | 37924157 | PubTator, text mining | PubMed |
| Organ-on-a-chip models for development of cancer immunotherapies. | Cancer Immunol Immunother | 2023 | 37923890 | PubTator, text mining | PubMed |
| Hypoxia increases persulfide and polysulfide formation by AMP kinase dependent cystathionine gamma lyase phosphorylation. | Redox Biol | 2023 | 37922764 | PubTator, text mining | PubMed |
| Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review). | Mol Clin Oncol | 2023 | 37920415 | PubTator, text mining | PubMed |
| CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors. | Front Immunol | 2023 | 37915564 | PubTator, text mining | PubMed |
| Targeting STEAP1 as an anticancer strategy. | Front Oncol | 2023 | 37909017 | PubTator, text mining | PubMed |
| Advances in CAR-Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies. | Adv Sci (Weinh) | 2023 | 37906032 | PubTator, text mining | PubMed |
| Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder. | Gen Psychiatr | 2023 | 37901286 | PubTator, text mining | PubMed |
| The tumor micro-environment in pediatric glioma: friend or foe? | Front Immunol | 2023 | 37901250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=17